GO
Loading...

Lightning Round: Apple, Arena Pharma & More

Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

Pharmacyclics (PCYC): I'm a buyer, said Cramer. I think their new cancer drug gets FDA approval.

Arena Pharmaceuticals (ARNA): I'd stay away from this one, said Cramer. It's not for me.

Getty Images

Advanced Micro Devices (AMD): This is a one trick pony, said Cramer.

Cheniere Energy (LNG): I like owning the Cheniere master limited partnership more, said Cramer.

Windstream Holdings (WIN): I don't trust this one, said Cramer. There are better places in the market to make money.

Ubiquiti Networks (UBNT): I'm sticking with it, said Cramer.

Columbia Banking System (COLB): I like it for the long-term, said Cramer. It's a winner.

Apple (AAPL): Lately, I've come to view Apple as the Rodney Dangerfield of stocks, said Cramer. It doesn't get any respect.

Weatherford Int'l (WFT): All I can say is, it's not as bad as it used to be, said Cramer. In the space I like Schlumberger much more.

Call Cramer: 1-800-743-CNBC
Questions for Cramer? madmoney@cnbc.com
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
PCYC
---
ARNA
---
SWKS
---
AMD
---
LNG
---
WIN
---
UBITUITI NET
---
COLB
---
AAPL
---
WFT
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.